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Abstract 
Background: Fingertip injuries treated with occlusive dressings (ODs) lead to nearly scar‑free, functionally, and 
aesthetically pleasing results. We hypothesized that paracrine factors in the wound fluid (secretome) may influence 
migration and proliferation of mesenchymal stem cells (MSCs) and fibroblasts and modulate the wound‑healing 
process.
Methods: We could collect wound fluid samples from 4 fingertip injuries and 7 split skin donor sites at the 5th day 
during dressing change. Blood serum samples served as controls. The proliferation rate of MSCs and fibroblasts (HS27) 
was continuously measured through impedance analysis for 60 h and by Alamarblue analysis after 72 h. Cell migra‑
tion was evaluated continuously for 15 h and confirmed by the in vitro wound‑healing assay.
Results: Migration of MSCs under the influence of both wound fluids was significantly faster than controls from 4 to 
6 h after incubation and reversed after 9 h. MSC proliferation in wound fluid groups showed a significant increase at 
5 and 10 h and was significantly decreased after 45 h. Fibroblasts in wound fluid groups showed overall a significant 
increase in migration and a significant decrease in proliferation compared to controls.
Conclusion: OD‑induced secretomes influence MSCs and fibroblasts and thereby possibly modulate wound healing 
and scar tissue formation.
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Background
Adult wound healing aims at rapidly closing a defect 
and reestablishing the skin barrier to prevent any fur-
ther infection and fluid loss [1]. This process is com-
monly divided into at least three overlapping stages: 
inflammation, proliferation, and remodeling [2]. In 
inflammation, after initial hemostasis by the aggregation 
of platelets, the release of chemoattractants and growth 
factors recruits fibroblasts and leukocytes [2]. In prolif-
eration, granulation tissue is predominantly formed by 
fibroblasts and macrophages, creating a new extracellu-
lar matrix, which allows epithelization, angiogenesis, and 
fibroplasia to take place [3]. Finally, in remodeling, col-
lagen type III is replaced with collagen type I, resulting in 
a stable scar [3]. This whole process is reparative rather 
than regenerative, as the final scar tissue is a disturbance 
of the normal skin function, structure, and architecture 
with a reduced tensile strength by about 20–30% [4, 5].
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In general, a scar is composed of excess extracellular 
matrix (ECM) compared to normal, uninjured dermal 
tissue and is devoid of epidermal appendages [5]. Purely 
regenerative healing of an inflicted wound in humans 
occurs in fetal wound healing up to 24 weeks of gestation 
[6]. It was demonstrated that fetal wounds differ from 
adult wounds in inflammatory response, gene expression, 
growth factor release as well as extracellular matrix pro-
duction [7]. In scars, the extracellular matrix of the new 
dermis is abnormally deposited as small parallel bundles 
of collagen types I, III and fibronectin. In the non-injured 
skin, these bundles are large and appear in a basketweave 
orientation, suggesting a structural problem in the regen-
erative process [8]. Adult tissue loses the regenerative 
capacity and clinical problems owing to scars are mani-
fold, including pathologies like keloids and hypertrophic 
scars, as well as symptoms like itching, pain or inhibition 
of movement due to contractions of joints [9].
However, also in adult wound healing, there are cer-
tain types of wounds which can heal nearly scar-free, 
resulting in a good aesthetic and functional outcome. 
Fingertip injuries treated with occlusive dressings (ODs) 
may regenerate up to 90% of the initial soft tissue loss, 
regenerate dermal ridges, and result in a good sensibil-
ity of the previously injured skin [10]. ODs create a moist 
wound environment and seem to play a key role for the 
favorable results seen in non-surgically treated finger-
tip amputations. As early as 1965, the effect of occlusive 
dressings was compared to air-exposed healing in human 
skin wounds by Hinman et  al. [11]. In 1983, Soderberg 
et  al. compared fingertip injuries treated with adhesive 
zinc tape dressings to surgical therapies. The authors 
found a better 2-point-discrimination sensitivity, as well 
as less scars and pain in patients treated with dress-
ings alone [12]. Mennen and Wiese treated 200 patients 
with fingertip injuries with semi-occlusive dressings and 
reported excellent results, a near normal fingertip shape 
and a comparable sensitivity to the non-injured hand in 
between 20 and 30 days after the injury [13].
ODs allow the development of a moist wound environ-
ment, which immerses the cells and has been shown to 
increase collagen synthesis and to accelerate the rate of 
re-epithelialization [14, 15]. We hypothesized that the 
pivotal factor triggering such pro-regenerative stimuli 
underneath ODs is a direct effect of the wound fluid. 
This wound fluid is the sum of all biological substances, 
secreted from the sterile wound, and contains the 
secretome of the cells in the wound area. We have shown 
before that this secretome can change under wound con-
ditions and can modulate wound-healing processes like 
angiogenesis [16–18].
In this study, we investigated the influence of such 
wound fluid from ODs on the behavior of mesenchymal 
stem cells (MSCs) and fibroblasts (FBs), important mod-
ulators of the wound-healing process.
Methods
The study protocol conformed to the guidelines of the 
1975 Declaration of Helsinki as reflected in the approval 
of our local ethics committee (No. 527/15). 4 Fingertip 
injuries (Allen stages II–III) were treated with occlu-
sive dressings (Smith & Nephew IV3000) after initial 
wound care. In addition, we treated 7 split skin donor site 
wounds (at the ventro-medial to ventro-lateral upper leg 
of the patients) with the same occlusive dressings post-
operatively. At the 5th day, we tried to harvest fluid sam-
ples after obtaining informed consent from any patient 
while changing the dressings. This was done with a small 
syringe puncturing the dressing without injuring the 
patient’s skin. The fingertip injuries were dressed leaving 
a small reservoir at the top to allow a fluid collection, as is 
necessary for the functionality of the therapy (see Fig. 1) 
[19, 20]. We collected fluid from 4 fingertip injuries from 
4 patients (minimum 60 µl, median 91 µl, and maximum 
120 µl) and 7 split skin donor sites from 7 patients (mini-
mum 3800 µl, median 2700 µl, and maximum 11,200 µl). 
Both patient groups had comparable demographics with 
an average age of 53 years in the fingertip group (range 
52–55) and 55 years in the split skin group (range 39–82) 
without any comorbidities. The male-to-female ratio was 
2:2 in the fingertip group and 2:5 in the split skin group.
Blood serum from each patient was drawn as con-
trols (minimum 800  µl, median 2000  µl, and maximum 
2500  µl). Due to limitations of fluid quantity per sam-
ple, we used 4 fingertip fluid samples and 4 of the 7 split 
Fig. 1 Wound fluid collection in a predesigned reservoir of an 
occlusive wound dressing of a patient with split skin donor site (left) 
and a fingertip amputation (right) (in the red circle)
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skin fluid samples with respective blood serum controls 
in the Alamarblue Assay and xCELLigence analysis. The 
remaining 3 split skin donor site samples were analyzed 
in the in vitro wound-healing assay (Ibidi, Germany).
Cell culture
HS-27, a commercially available human derived fibro-
blast cell line (ATCC—LGC Standards, Germany), was 
cultured in DMEM (Biochrom, Germany) supplemented 
with 10% FCS. HS-27 cells are human foreskin fibro-
blasts which are growing adherent to cell-culture plastic. 
We used adipose-derived MSCs also known as adipose-
derived stem cells (ASCs or ADSCs) isolated from aes-
thetic liposuction, as previously described [21]. The 
cells were characterized in our lab by their expression of 
CD73, CD90, and CD105 as well as their potency to dif-
ferentiate into fat cell, chondrocytes, and osteoblasts. For 
cultivation, MEM-alpha (Biochrom, Germany), contain-
ing 10% FCS was used.
Cell metabolism assay (Alamarblue)
MSCs were seeded in a density of 8000 cells/well and 
HS-27 FBs in a density of 4000 cells/well in 96 well plates 
using standard cultivation media as described above. 
Cells were allowed to attach overnight, then the medium 
was replaced with sample (wound fluid or serum) in a 
concentration of 10%. Alamarblue assay (Sigma-Aldrich) 
was performed after 3 days of incubation at 37 °C in 5% 
 CO2 atmosphere according to the instructions of the 
manufacturer. In short, Alamarblue reagent was added to 
the cells and incubated for 30 min, followed by fluores-
cence measurement at Ex 530 nm/Em 600 nm.
Impedance proliferation assay (xCELLigence)
The xCELLigence device enables the continuous analy-
sis of cell proliferation. The proliferation rates of MSCs 
and HS27 fibroblasts were determined with the xCEL-
Ligence-DP Analyser  (OLS® Omni Life Sciences, Ger-
many). We seeded 4000 HS-27 FBs and 8000 MSCs in 
individual wells and incubated them with standard culti-
vation medium for 40 h. Wound fluid or serum was pre-
diluted 1:10 in standard medium before it was added to 
the seeded wells in a ratio of 1:1 to achieve a final sam-
ple concentration of 5%. Continuous measurement of 
impedance (Cell index) started 30 min after seeding and 
was performed in intervals of 15 min for 100 h. Analysis 
was done for the first 60 h.
Impedance migration assay (xCELLigence)
Migration analysis was performed in CIM plates in 
combination with xCELLigence-DP-Analyzer  (OLS® 
Omni Life Sciences). The CIM plate consists of an upper 
chamber with a porous membrane and a lower cham-
ber. 40,000 HS-27 FBs or MSCs were seeded in standard 
medium in the wells of the upper chamber and left for 
30 min to settle. As chemoattractant 5% wound exudate 
or 5% serum, diluted in standard medium, was filled in 
the wells of the lower chamber. Impedance measurement 
at the lower side of the porous membrane was carried out 
to visualize cell migration from the upper to the lower 
chambers. Impedance read out was expressed as cell 
index and executed every 15 min to a maximum of 25 h. 
Analysis was done for the first 15 h.
In vitro wound‑healing assay (Ibidi)
We first pipeted 70 μl cell suspension (1.2 × 105 cells/ml) 
in each of the 24 wells of Ibidi culture inserts (Ibidi, Ger-
many). Next, cells were incubated at 37 °C and 5%  CO2 for 
24 h to obtain a confluent cell layer. Culture inserts were 
removed afterwards and cell layers washed with PBS. 
Filled plate wells were prepared with culture medium 
(Dulbecco’s MEM by Merck Millipore, 2% wound fluid 
and 1% antibiotic/antimycotic ingredient by Capricorn, 
AAS-B) up to 500 μl. Wells filled with medium without 
wound fluid were used as negative controls. Microscopy 
pictures were taken at 0 h, 6 h, 12 h, and 24 h and images 
were analyzed using the WimScratch software.
The statistical analysis
Data are shown as mean ± SEM. Statistical analysis 
between the groups was performed using unpaired t 
tests. p values of less than 0.05 were considered statisti-
cally significant.
Results
Migration assay (xCELLigence impedance)
The migration of MSCs under the influence of fin-
gertip fluid measured with xCELLigence was signifi-
cantly increased at 4  h (p = 0.046), 5  h (p = 0.032) and 
6  h (p = 0.048) compared to blood serum controls of 
the same patients. This effect reversed significantly in 
the MSC population of occlusive treated fingertip inju-
ries after 11  h (p = 0.047) and continued afterwards 
(see Fig. 2). MSCs under the influence of split skin fluid 
showed initially a trend towards an increased migration 
compared to respective serum controls, which was not 
significant. A significant decrease of MSC migration, 
influenced by split skin donor site fluid, was found start-
ing at 9  h after incubation (p = 0.049) and continued to 
do so (see Fig. 2). Combined analysis of MSC migration 
of both wound fluids compared to both serum controls 
showed a significant increase from 3 h (p = 0.023) to 6 h 
(0.017) with the strongest increase at 4  h (p = 0.001). 
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A significant decrease in MSC migration of all fluids 
compared to all serum values started at 9  h (p = 0.034) 
onwards (see Fig. 2).
The migration of HS27-FBs of fingertip fluids in xCEL-
Ligence was significantly increased at 5  h (p = 0.041), 
6  h (p = 0.043) and 7  h (p = 0.049) compared to respec-
tive serum controls (see Fig.  3). The migration of HS27 
FBs of split skin fluid alone did not show any significant 
changes, but mimicked the curve of the fingertip fluid 
values with a less steep increase and decline after a few 
hours. Analyzing the migration HS27 FBs of all wound 
fluid samples compared to all serum samples showed 
a significant increase between 5 and 10  h after sample 
incubation (p = 0.004) (see Fig. 3).
Fig. 2 Time‑dependent MSC migration in wound fluid groups vs. control groups. All groups in mean ± SEM. *p < 0.05 mean fingertip fluids vs. 
mean fingertip serums. +p < 0.05 mean split skin fluids vs. mean split skin serums. #p < 0.01, Ωp < 0.05 mean all fluids vs. mean all serums
Fig. 3 Time‑dependent HS27 FB migration in wound fluid groups vs. control groups. All groups in mean ± SEM. *p < 0.05 mean fingertip fluids vs. 
mean fingertip serums. #p < 0.01 mean of all fluids vs. mean all serums
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In vitro wound‑healing assay
The in vitro wound-healing assay showed a significantly 
increased HS27 FB migration at 12  h (p = 0.012) and at 
24 h (p = 0.017) compared to the control, supporting our 
data from the impedance analysis (see Figs. 4, 5).
Proliferation I (xCELLigence impedance)
We observed a non-significant increase of cell prolifera-
tion of MSCs exposed to each fluid alone at 5 h (finger-
tips p = 0.061, split skin donor sites p = 0.511) and 10  h 
(fingertips p = 0.091, split skin donor sites p = 0.511). 
By comparing of all fluid samples with the respective 
serum samples, we observed a significant increase at 
5 h (p = 0.034) and 10 h (p = 0,041). However, this effect 
was reversed at 15  h. A significant decrease in MSC 
proliferation of both wound fluids combined compared 
to the controls was seen starting at 45  h of incubation 
(p = 0.046) and later (see Fig.  6). The proliferation of 
HS27 FBs showed initially a slow decrease in both flu-
ids, which was significant in the fingertip fluid group 
Fig. 4 HS27 FB migration in the in vitro wound‑healing assay. All groups in mean ± SEM. +p < 0.05 mean split skin fluids vs. mean controls
Fig. 5 Representative microscopic images of cell migration at different time points in the in vitro wound‑healing assay using 100‑times 
magnification (scale bar size: 100 μm)
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compared to the control group at 15  h (p = 0.012) and 
20 h (p = 0.030). The pooled analysis of HS27 FB prolifer-
ation of all fluids compared to all serum controls was sig-
nificantly decreased from 15 h (p = 0.022) to 25 h (0.039), 
continuing to be so at 40 h (p = 0.044) onward (see Fig. 7).
Cell metabolism/proliferation II (Alamarblue)
HS27 FBs were significantly reduced in the fingertip 
fluid group compared to respective controls (p = 0.006), 
whereas MSCs were significantly decreased only in the 
split skin fluid group compared to controls (p = 0.0448). 
We saw a significant decrease in MSC proliferation 
exposed to both combined wound fluids compared to 
blood serum controls (p = 0.008). HS27 FB proliferation 
also decreased in both pooled fluid groups significantly 
compared to the controls (p = 0.003) after 3 days of sam-
ple incubation (see Fig. 8).
Fig. 6 Time‑dependent MSC proliferation in wound fluid groups vs. control groups. All groups in mean ± SEM. Ωp < 0.05 mean all fluids vs. mean all 
serums
Fig. 7 Time‑dependent HS27 FBs proliferation in wound fluid groups vs. control groups. All groups in mean ± SEM. *p < 0.05 mean fingertip fluids 
vs. mean fingertip serums. Ωp < 0.05 mean all fluids vs. mean all serums
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We did not observe any statistically significant dif-
ference in the behavior of mesenchymal stem cells and 
fibroblasts between samples from fingertip or split skin 
donor site wound fluids.
Discussion
A moist wound environment stimulates fibroblast pro-
liferation, enhances the expression of growth factors, 
and induces angiogenesis, which finally leads to a faster 
regeneration [22, 23]. In addition, the formation of scars, 
as well as scar quality in general is improved, achieving 
a better functional and aesthetic outcome [24]. These 
effects on scars might be due to a shorter inflammation 
and proliferation phase in moist dermal wound healing 
compared to dry dressing changes [25]. In line with this 
hypothesis, Ksander et  al. demonstrated that moisture 
vapor-permeable dressings inhibited the deposition of 
granulation tissue and collagen compared to air-exposed 
wounds in animal models. Histologic results of these 
wounds showed large amounts of fibrous connective 
tissue with mononuclear and polymorphonuclear cells 
in air-exposed wounds, whereas wounds treated with 
moist dressings showed a lack of these tissues and cells 
as well as decreased inflammation [26]. O’Shaughnessy 
et  al. demonstrated that occlusion reduces epidermal 
water loss and may restore the homeostasis of the epi-
dermal barrier, which decreases hypertrophic scarring 
and inflammation-specific cells like macrophages [27]. 
However, the interplay of FBs and MSCs in moist wound 
healing and the influence of wound exudate on local cells 
in the wound bed is incompletely understood.
The formation of granulation tissue and cellular inter-
actions in the inflammatory and proliferation phases 
seems to differ significantly in moist wound healing com-
pared to air-exposed wounds [25, 26, 28]. Fibroplasia and 
the creation of granulation tissue are mainly dependent 
on fibroblasts, which are the dominant cell type by day 4 
of wound healing and peak at 7–14 days after injury [29, 
30]. Platelet-derived growth factor (PDGF), basic fibro-
blast growth factor (bFGF), and transforming growth 
factor-β (TGF-β) modulate the initial migration and 
proliferation of fibroblasts, which then reorganize and 
replace the provisional matrix through synthesis and the 
release of collagen [31, 32]. Finally, in remodeling which 
takes up to 2 years, the provisional matrix is restructured 
by matrix metalloproteinases to increase tensile strength, 
resulting in a scar [3].
As important as fibroblasts are for the formation of the 
proliferative tissue, the production of collagen and finally 
its differentiation into myofibroblasts to allow wound 
contraction is mainly induced by MSCs, which are the 
important modulators every step of the way [33]. In the 
inflammatory phase, MSCs act as anti-inflammatory 
agents by increasing anti-inflammatory cytokines like 
interleukin-10 (IL-10) and IL-4, as well as prohibiting 
the secretion of pro-inflammatory cytokines like TNF-α 
and Interferon-γ [34]. In chronic wounds, all wound-
healing phases are prolonged, with immense infiltration 
Fig. 8 Proliferation of MSCs and HS27 FBs after 3 days of sample incubation. All groups in mean ± SEM. *p < 0.01 mean fingertip fluids vs. mean 
fingertip serums. +p < 0.05 mean split skin fluids vs. mean split skin serums
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by neutrophil granulocytes [35]. MSCs can interrupt 
this cycle and allow wound healing by decreasing the 
inflammatory state, by promoting cell migration and 
proliferation as well as by induction of angiogenesis [36]. 
Our results demonstrate a trend towards an increase 
in wound-healing quality, where a strong migration of 
MSCs and fibroblasts possibly allow the multiple tasks of 
these cells to take place, but limiting an overabundance of 
fibroblasts, which is known to be found in hypertrophic 
scars [4].
MSCs act predominantly by paracrine signaling and 
can secrete cytokines and growth factors like PDGF, 
vascular endothelial growth factor (VEGF), epidermal 
growth factor (EGF), bFGF, keratinocyte growth fac-
tor (KGF), and TGF-β, thus modulating the prolifera-
tive phase of wound healing [36]. Studies showed that 
medium conditioned with MSCs or MSCs alone induces 
dermal fibroblasts to increase the rate of wound closure 
and that MSCs stimulate the proliferation of fibroblasts, 
endothelial cells, and keratinocytes in  vitro [37]. In 
response to MSC stimulation, collagen type I is increased 
by dermal fibroblasts, thus accelerating wound closure 
[37]. Taken these findings together, MSCs may directly 
influence a decrease in scar formation by inducing organ-
ized extracellular matrix (ECM) deposition [33].
Scar and wound modulation by occlusive dressings
Recent studies showed that hypoxic stimuli seem to 
mobilize MSCs from the wound bed and that continu-
ous hypoxia increases MSC mobilization by supposedly 
upregulation of hypoxia-induced factor-1α (HIF-1α) 
[38]. In our study, we demonstrated a significant increase 
of MSC mobilization when exposed to fluid from OD 
wounds, possibly showing one more factor involved in 
modulating wound repair. Here, we observed a stronger 
increase of MSC migration in the fingertip fluid group as 
in the occlusive-dressed split skin fluid group. As MSC 
motility decreases after reaching a plateau in our experi-
ments, there seem to be further mechanisms in the reg-
ulation of MSC activity involved. Occlusive dressings, 
which maintain a hypoxic wound environment, could be 
responsible for the observed positive effects on wound 
healing [14, 15].
It would have been very interesting to study the con-
tents of the secretome in our wound fluids in more detail, 
but unfortunately, we were restricted by the amount 
of fluid that could be obtained from our patients. Per 
patient, we only could obtain around 90 µl of fluid, so we 
had to decide to either study the proteomic content or 
do cell-culture analysis. Here, we decided to focus on the 
cell behavior modulation of fibroblasts and MSCs. For-
tunately, there are already data available about the con-
tents of such wound fluids: Vogt et  al. analyzed wound 
fluid from occlusive-dressed fingertip injuries on growth 
factors and found upregulated bFGF, epidermal growth 
factor (EGF), interleukin-1α (IL-1α), and TGF-β2 com-
pared to blood serum values, which could be a reason 
why ODs on fingertip injuries show a strong regenera-
tive potential [39]. It was hypothesized that wounds heal 
faster due to fibroblast and keratinocyte proliferation, 
increased angiogenesis, and growth factor expression 
[22, 23]. As fibroplasia and the formation of granulation 
tissue mainly bases on an initial burst of fibroblast activ-
ity, scar quality should not be increased due to an over-
abundance of proliferating fibroblasts, which are often 
seen in hypertrophic scars [35]. Our results show that 
fibroblast proliferation seems to be inhibited by occlu-
sive-dressed wound fluids, which could be another major 
factor to initiate a favorable scar modulation process. 
These data are corroborated by a recent study, showing 
that inhibiting a known-scar-forming fibroblast lineage 
during wound healing did not lead to a change of healing 
rates during the initial days of wound healing. However, 
a significant difference in wound size developed by day 
9 after wounding, with larger and less healed wounds in 
the treated cohorts. Most importantly, treated wounds 
showed significantly reduced final scar size after comple-
tion of wound healing [40]. Similarly, we could observe a 
spike of fibroblast mobility in the first 10 h after sample 
incubation, which afterwards decreased significantly. As 
fibroblasts are important players in the wound-healing 
process, their active role in the inflammatory and pro-
liferative phase of wound healing is essential [35]. In dry 
wound healing, a fast wound closure is important to min-
imize fluid loss and reduce the risk of infection, thus an 
increased fibroblast proliferation and activity is necessary 
to minimize these risks, but leading to a scar [1]. A super-
ficial occlusive barrier, allowing wound fluid to cover the 
wound, seems to inhibit excessive fibroblast proliferation, 
as we could show in our study. Interestingly, this effect 
was more pronounced in the fingertip fluid samples as in 
the split skin fluid samples, which could be responsible 
for the good clinical outcomes observed in occlusively 
dressed fingertip injuries. In addition, split skin fluids 
showed a significantly decreased MSC proliferation after 
3  days, which was not that prominent in the fingertip 
fluid group, suggesting that also other factors contribute 
to the positive effects of ODs in wound healing [25].
Limitations
Our results were generated in a simplified in vitro model 
of cell migration and proliferation. This is limited by sev-
eral factors: the wound fluid is only administered once 
in the model, while it is presumably constantly pro-
duced in the in  vivo wound situation. Thus, the results 
in the early hours of the experiment may reflect the 
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wound environment better than the later data. In  vivo, 
the wound is an injured 3D-tissue consisting of extra-
cellular matrix and a multitude of cells that constantly 
interact with each other through autocrine, paracrine, 
electrical, and mechanical cues that are not reproduced 
in the model. On the other hand, this approach allowed 
us to isolate effects of the wound fluid on two specific cell 
types that are thought to be important in wound healing, 
which is not as easily possible in a more complex model.
Conclusion
Using advanced cell surveillance technology, we could 
demonstrate a time-dependent and cell-type-related 
effect of wound fluid on migration and proliferation 
of mesenchymal stem cells and fibroblasts. This time-
resolved information revealed cell behavior that is nearly 
impossible to study in endpoint measurements. MSCs 
are important modulators of the proliferation stage in 
wound healing and play an important role in the forma-
tion of scar tissue. The early activation of MSC migration 
could modulate initial tissue composition and thereby 
scar tissue formation. Fibroblast proliferation seems to be 
inhibited in occlusively dressed wounds and may improve 
the organization of collagen structure on the wound. This 
well-orchestrated interplay between stromal cells may 
be partially responsible for the improved wound-healing 
process and scar quality, which are seen in fingertip inju-
ries and split skin donor sites treated under occlusive 
conditions.
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